News

The PMCPA website has been updated

The PMCPA website has been updated - to view this you may need to clear the cache on your browser.

Press release: 06 November 2024

Novo Nordisk, Moderna, Otsuka, AstraZeneca and Daiichi Sankyo named in advertisements for breaches of the ABPI Code

Clause 2 Adverts - press release

Press release: 24 October 2024

2024 Code Clause 12 Q&As - updated

The 2024 Code Clause 12 Q and As - updated to include new Q and on 14 October 2024

Press release: 14 October 2024

Webinars on changes in 2024 Code and an interactive e-learning module have been published

Three ‘On demand’ webinars explaining the changes in the 2024 ABPI Code are now available free of charge on the new dedicated learning portal for the Prescription Medicines Code of Practice Authority (PMCPA).

An interactive e-learning module targeted at individuals requiring an overview of the ABPI Code has now also been launched on the learning portal.

Press release: 10 October 2024

Documents outlining the changes to the ABPI Code (Updated)

Press release: 01 October 2024

2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA

Press release: 23 September 2024

PMCPA Annual Report 2022 and 2023

Press release: 09 September 2024

New Appointments at the PMCPA

Press release: 09 September 2024

Novartis, Pfizer, Otsuka and Novo Nordisk named in advertisements for breaches of the ABPI Code

Press release: 05 July 2024

ABPI Code of Practice training

Press release: 02 July 2024

New webform for companies to submit nominated signatories

Press release: 20 June 2024

Consultation on proposed changes to the 2021 ABPI Code and PMCPA Constitution and Procedure - Update

Press release: 13 June 2024

News

PMCPA News